Additionally, METTL3 facilitates immune escape in non-alcoholic fatty liver disease-associated HCC (NAFLD-HCC) by promoting cholesterol biosynthesis, which further impairs CD8+ T cell function. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatotic liver disease.